that’s the issue with using patient derived autologous t-cells, they’re generally already damaged/diminished from previous lines of treatment. These cells are already compromised, before having to have a CAR added to them and then expanded into the millions
IMO donor derived allogeneic cells, from already healthy people, is the future of cell therapy, which I’m pretty sure NK Cells are.
CHM Price at posting:
0.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)